Enanta Pharmaceuticals, Inc. (ENTA)
13.60
-0.20
(-1.45%)
USD |
NASDAQ |
Aug 28, 16:00
13.58
-0.02
(-0.11%)
After-Hours: 20:00
Enanta Pharmaceuticals 1 Year Total Returns (Daily) : 56.50% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 56.50% |
| August 27, 2026 | 61.78% |
| August 26, 2026 | 63.58% |
| August 25, 2026 | 62.59% |
| August 24, 2026 | 59.68% |
| August 21, 2026 | 56.81% |
| August 20, 2026 | 48.87% |
| August 19, 2026 | 61.02% |
| August 18, 2026 | 62.79% |
| August 17, 2026 | 60.38% |
| August 14, 2026 | 70.03% |
| August 13, 2026 | 77.31% |
| August 12, 2026 | 96.79% |
| August 11, 2026 | 108.3% |
| August 10, 2026 | 100.1% |
| August 07, 2026 | 97.00% |
| August 06, 2026 | 87.36% |
| August 05, 2026 | 78.41% |
| August 04, 2026 | 87.61% |
| August 03, 2026 | 82.14% |
| July 31, 2026 | 66.23% |
| July 30, 2026 | 70.83% |
| July 29, 2026 | 53.70% |
| July 28, 2026 | 57.04% |
| July 27, 2026 | 72.03% |
| Date | Value |
|---|---|
| July 24, 2026 | 74.11% |
| July 23, 2026 | 67.53% |
| July 22, 2026 | 70.27% |
| July 21, 2026 | 73.61% |
| July 20, 2026 | 74.54% |
| July 17, 2026 | 90.04% |
| July 16, 2026 | 86.04% |
| July 15, 2026 | 100.8% |
| July 14, 2026 | 88.36% |
| July 13, 2026 | 107.9% |
| July 10, 2026 | 96.28% |
| July 09, 2026 | 99.86% |
| July 08, 2026 | 86.97% |
| July 07, 2026 | 86.41% |
| July 06, 2026 | 83.90% |
| July 02, 2026 | 89.59% |
| July 01, 2026 | 91.82% |
| June 30, 2026 | 92.86% |
| June 29, 2026 | 93.47% |
| June 26, 2026 | 86.42% |
| June 25, 2026 | 80.54% |
| June 24, 2026 | 87.43% |
| June 23, 2026 | 97.47% |
| June 22, 2026 | 86.21% |
| June 18, 2026 | 75.10% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Perspective Therapeutics, Inc. | -7.99% |
| AbbVie, Inc. | 26.69% |
| Coherus Oncology, Inc. | 19.49% |
| BridgeBio Pharma, Inc. | 45.71% |
| RenovoRx, Inc. | 76.23% |